KRDI in Transplant-Eligible MM

NCT04430894 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Carfilzomib
DRUG: Isatuximab
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]